Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYH2069 in Type 2 Diabetes Mellitus
NCT07796477Phase 2Not yet recruiting
- Sponsor
- CSPC Ouyi Pharmaceutical
- Start
- Nov 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of SYH2069 in type 2 diabetes mellitus (T2DM), sponsored by CSPC Ouyi Pharmaceutical. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
SYH2069
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07796477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07796477.